Red flags / Dilution
NewGenIvf Group prices firm-commitment offering of Class A shares and pre-funded warrants after repeated reverse splits
NewGenIvf Group Limited filed a preliminary 424B5 prospectus supplement for a firm-commitment underwritten offering of Class A ordinary shares and pre-funded warrants, with the number of shares and offering price still blank. The filing states the stock closed at US$0.17 on November 18, 2026, and that the company has effected ten reverse stock splits since 2025 and has board approval for another 1-for-100 split. Offerings of this size relative to a company with a sub-dollar stock and a history of listing deficiencies typically dilute existing holders heavily.
“On November 18, 2026, the last reported sale price of our Class A Ordinary Shares on Nasdaq was US$0.17 per share.”
What the stock did
From the last close before the filing was public. Market cap now: $0M.
Prospectus supplement or shelf for new shares, including at-the-market programs. Flags are a screen for filings worth reading, not advice. Read the filing before acting on it.
Other flags on NIVF
| Filed | Stock | Flag | What the filing says | Mkt cap | 5 days | 20 days |
|---|---|---|---|---|---|---|
| Nov 20, 9:00 AM ET | NIVF NewGenIvf Group Limited | Dilution SevereForm 424B5 | NewGenIvf Group prices firm-commitment offering of 70.3 million pre-funded warrants at $0.035 per share | $0M | - | - |
| Oct 27, 8:59 AM ET | NIVF NewGenIvf Group Limited | Dilution WatchForm F-3 | NewGenIvf Group Limited filed a new F-3 shelf registration | $0M | -20.2% | - |